|
Market Closed -
Nasdaq Stockholm
09:30:00 08/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,546.50 SEK | -1.28% |
|
-0.58% | -9.22% |
| 09/09 | AstraZeneca PLC : Gets a Buy rating from RBC | ZD |
| 09/09 | Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,02400Cr | |||||
| 66TCr | - | - | - | ||
| 45TCr | |||||
| 35TCr | |||||
| 29TCr |
Select your edition
All financial news and data tailored to specific country editions
